Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study-Reference-Cited by-同舟云学术

Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study

Published:2018-07-15 Issue:8 Volume:25 Page:737-745
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Sakalis Vasileios¹,Sfiggas Vasileios¹,Vouros Ioannis¹,Salpiggidis George¹,Papathanasiou Athanasios¹,Apostolidis Apostolos²

Affiliation:

1. Department of Urology; Hippokration Hospital; Thessaloniki Greece

2. 2nd Department of Urology; Papageorgiou General Hospital; Aristotle University of Thessaloniki; Thessaloniki Greece

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13721/fullpdf

Reference32 articles.

1. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: A direct comparison;Levin;Neurourol. Urodyn.,2000

2. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction;De Nunzio;J. Urol.,2003

3. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy;Steers;J. Urol.,1996

4. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder;Liu;J. Urol.,2008

5. Gravas S Bachmann A Descazeaud A et al Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) https://uroweb.org/wp-content/uploads/Non-Neurogenic-Male-LUTS_2705.pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs causing prostate-specific antigen changes: the food and drug administration adverse event reporting system combined with Mendelian randomization analysis;Expert Opinion on Drug Safety;2024-09-14

2. Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms;International Neurourology Journal;2021-03-31

5. Shedding light on polypragmasy of pain after transurethral prostate surgery procedures: a systematic review and meta-analysis;World Journal of Urology;2021-03-31